Insulet Corporation (PODD) 42.19 $PODD Will Insulet

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Insulet Corporation (PODD) 42.19 $PODD

Will Insulet (PODD) Crush Estimates at Its Next Earnings Report?
Zacks Equity Research - Zacks Investment Research - Thu Sep 01, 7:44AM CDT
Insulet (PODD) has seen a nice streak of beating earnings estimates and looks set to crush analyst expectations in its next earnings report
PODD: 42.19 (-0.14)

Uptrend Call Working As Insulet Stock Rises 35.8% (PODD)
Comtex SmarTrend(R) - Tue Aug 30, 1:21PM CDT
SmarTrend identified an Uptrend for Insulet (NASDAQODD) on July 8th, 2016 at $31.92. In approximately 2 months, Insulet has returned 35.81% as of today's recent price of $43.35.
PODD: 42.19 (-0.14)

Moving Average Crossover Alert: Insulet (PODD)
Zacks Equity Research - Zacks Investment Research - Tue Aug 16, 9:47AM CDT
Insulet Corporation (PODD) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front
PODD: 42.19 (-0.14)

38.3% Return Seen to Date on SmarTrend Insulet Call (PODD)
Comtex SmarTrend(R) - Mon Aug 15, 1:10PM CDT
SmarTrend identified an Uptrend for Insulet (NASDAQODD) on July 8th, 2016 at $31.92. In approximately 1 month, Insulet has returned 38.28% as of today's recent price of $44.14.
PODD: 42.19 (-0.14)

Can The Uptrend Continue for Insulet (PODD)?
Zacks Equity Research - Zacks Investment Research - Mon Aug 15, 8:15AM CDT
Investors certainly have to be happy with Insulet Corporation (PODD) and its short term performance
PODD: 42.19 (-0.14)

Shares of PODD Up 32.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Aug 05, 1:17PM CDT
SmarTrend identified an Uptrend for Insulet (NASDAQODD) on July 8th, 2016 at $31.92. In approximately 4 weeks, Insulet has returned 32.82% as of today's recent price of $42.40.
PODD: 42.19 (-0.14)

After Yesterday's Rally of 21.61% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu Aug 04, 12:56PM CDT
Insulet (NASDAQODD) traded in a range yesterday that spanned from a low of $39.25 to a high of $43.48. Yesterday, the shares gained 21.6%, which took the trading range above the 3-day high of $36.31 on volume of 2.3 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PODD: 42.19 (-0.14)

Insulet Reports Second Quarter 2016 Financial Results
BusinessWire - Wed Aug 03, 3:01PM CDT
--Company Raises Mid-Point of Full Year 2016 Revenue Guidance by $10 Million
PODD: 42.19 (-0.14)

Insulet Corporation to Present at Upcoming Investor Conferences
BusinessWire - Mon Aug 01, 3:05PM CDT
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod(R) Insulin Management System, today announced that management will present at three upcoming investor conferences in New York City, New York:
PODD: 42.19 (-0.14)


Health insurer's limit on insulin pumps worries patients
By TOM MURPHY - AP - Fri Jun 24, 10:18AM CDT
Stephanie Rodenberg-Lewis wasn't happy with her insulin pump and finally switched two years ago to another brand. Now her health insurer is pushing her to go back.
PODD: 42.19 (-0.14), UNH: 135.56 (-0.49), AET: 115.99 (-1.13)

What Investors are Making of These Healthcare Stocks? - Antares Pharma, Globus Medical, NuVasive, and Insulet
PR Newswire - Fri Jun 24, 6:49AM CDT
Since the financial crisis, the Healthcare sector has proven to be defensive against market downturns, continuing to present opportunities for growth. Today's featured companies on Stock-Callers.com belong in this arena: Antares Pharma Inc. (NASDAQ: ATRS), Globus Medical Inc. (NYSE: GMED), NuVasive Inc. (NASDAQ: NUVA), and Insulet Corp. (NASDAQ: PODD). Learn more about these stocks and receive your complimentary trade alerts at:
PODD: 42.19 (-0.14), GMED: 23.36 (+0.13), NUVA: 65.81 (+0.34), ATRS: 1.22 (unch)

First Week of PODD August 19th Options Trading
DividendChannel.com - Tue Jun 21, 9:49AM CDT
Investors in Insulet Corp saw new options begin trading this week, for the August 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the PODD options chain for the new August 19th contracts and identified one...
PODD: 42.19 (-0.14)

Insulet Partners with Joslin Diabetes Center to Implement a Unique Training Certification for Insulet's Clinical Team
BusinessWire - Fri Jun 10, 5:00AM CDT
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod(R) Insulin Management System, today announced that almost 100 members of Insulet's North American clinical team have completed a customized certification program designed and led by the Joslin Diabetes Center for Insulet. The Advanced Diabetes Educator in Pump Therapy (ADEPT(TM)) certification provides Insulet's clinical team with customized, advanced training to deliver enhanced support for individuals who are managing their diabetes using continuous subcutaneous insulin infusion therapy. The Company's partnership with Joslin will enable Insulet's clinical team to provide unparalleled training and support for healthcare practitioners and their Omnipod patients.
PODD: 42.19 (-0.14)

Insulet to Present Omnipod(R) Clinical Studies on Type 1 and Type 2 Diabetes During the American Diabetes Association's 76th Scientific Sessions
BusinessWire - Wed Jun 08, 5:38PM CDT
--Dr. Frank Doyle to Share Exciting New Data on the Insulet-Licensed Artificial Pancreas Algorithm
PODD: 42.19 (-0.14)

Insulet Rises 2.31% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon May 23, 4:28PM CDT
Insulet (NASDAQODD) traded in a range yesterday that spanned from a low of $28.33 to a high of $29.42. Yesterday, the shares gained 2.3%, which took the trading range above the 3-day high of $28.86 on volume of 332,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
PODD: 42.19 (-0.14)

Insulet Launches New Omnipod(R) Podder(TM) Community Platform
BusinessWire - Mon May 23, 5:00AM CDT
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod(R) Insulin Management System (Omnipod System), today announced the launch of a new online user community platform. This new platform will increase patient engagement and awareness of Omnipod by empowering Omnipod customers to share their experiences and insights and provide support to the large and growing Podder(TM) community. The launch of the Podders community platform coincides with Insulet's exciting new patient mobile app and branding, as well as the Company's debut on social media via Facebook (myomnipod) and Twitter (@myomnipod).
PODD: 42.19 (-0.14)

Why Insulet Corporation and Tandem Diabetes Care Both Tanked Today
Brian Feroldi, The Motley Fool - Motley Fool - Tue May 03, 3:50PM CDT
PHOTO CREDIT: INSULET. What: Shares of Insulet Corporation  and Tandem Diabetes Care , both medical-device companies primarily focused on creating products that help treat diabetes, plunged by double digits today after Tandem released some...
PODD: 42.19 (-0.14), TNDM: 7.00 (-0.13)

Insulet Pumps Out 69% Revenue Growth in Q1, Reaffirms 2016 Guidance
Beth McKenna, The Motley Fool - Motley Fool - Tue May 03, 2:04PM CDT
Insulet    reported its first-quarter 2016 earnings after the market closed on Thursday. The drug delivery company, which is a leader in tubeless insulin pump technology with its OmniPod System, posted revenue growth that exceeded its...
PODD: 42.19 (-0.14), AMGN: 169.35 (-0.71)

Insulet Reaffirms Second Quarter and Full Year 2016 Guidance
PR Newswire - Tue May 03, 1:35PM CDT
Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System (OmniPod System), today reaffirmed its second quarter and full year 2016 guidance. A recent preferred provider communication by UnitedHealthcare regarding in-network DME insulin pumps is not expected to have a material impact on OmniPod System coverage nor on Insulet's financial results.
PODD: 42.19 (-0.14)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 77

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 125

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 258

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Bloomberg, HKEX Expand Offshore RMB Bond Indices

Updated Category News Views 44

A Move to Elevate Dim Sum Bonds If you're wondering what's cooking in the bond market arena, Bloomberg and HKEX just turned up the heat with a new family of RMB bond indices. These aren't just any run-of-the-mill indices; they're targeting the offshore RMB market, affectionately called the Dim Sum bond market. For those of us grizzled vets in the trading world, this is...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 92

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 415

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 316

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 309

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 233

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading

Top 5 Most Recently Viewed Articles

BJ's Wholesale Club Exceeds Expectations with Q4 Earnings

Updated Category News Views 131

BJ's Wholesale Club Achieves Impressive Q4 Results BJ’s Wholesale Club Holdings, Inc. (NYSE: BJ) has delivered a noteworthy performance in its latest financial results, showcasing resilience and growth in a competitive market. The company's fourth-quarter performance has not only exceeded expectations but also highlighted significant strengths in key operational areas....

Continue Reading
Elemeno Health Appoints Tim Coulter as New CEO for Growth

Updated Category News Views 433

Elemeno Health Welcomes Tim Coulter as New CEO Elemeno Health, a leader in microlearning solutions for healthcare staff, has made a significant announcement regarding its leadership. The company is thrilled to introduce Tim Coulter as its new Chief Executive Officer. With an impressive track record spanning over two decades in health technology and enterprise software,...

Continue Reading
Emerging Trends and Insights in the Amber Glass Packaging Market

Updated Category News Views 152

Growth and Innovation in Amber Glass Packaging The global amber glass packaging market has displayed strong resilience and growth potential. Recent studies indicate that this market, valued at USD 8.46 billion, is projected to reach USD 13.15 billion, indicating a robust compound annual growth rate (CAGR). This surge is driven by the multidimensional advantages of amber...

Continue Reading
FiEE, Inc. Celebrates Trading Resumption on Nasdaq as MINM

Updated Category News Views 273

FiEE, Inc. Announces Trading Resumption on Nasdaq The technology-driven company FiEE, Inc. is excited to share that it will resume trading on the Nasdaq under the existing symbol "MINM". This significant milestone follows a successful hearing with the Nasdaq Hearings Panel, which led to the decision to reinstate trading on the Nasdaq Capital Market. Details of the Trading...

Continue Reading
Vera Therapeutics Expands Talent with Inducement Awards

Updated Category News Views 209

Vera Therapeutics Expands Talent with Inducement Awards Vera Therapeutics, Inc. (Nasdaq: VERA) has recently taken a significant step towards enhancing its workforce by granting inducement awards. These awards, which were declared by the Compensation Committee on January 8, have been established to attract and retain six new employees. The inducement awards include a...

Continue Reading